NIT
CPRX

NumerixS Investment Technologies’s Catalyst Pharmaceutical CPRX Stock Holding History

NumerixS Investment Technologies’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-12,200
Closed -$56K – 192
2020
Q2 		$56K Buy
12,200
+8,000
+190% +$35.9K 0.02% 769
2020
Q1 		$16K Sell
4,200
-37,900
-90% -$156K 0.01% 832
2019
Q4 		$158K Buy
42,100
+39,600
+1,584% +$185K 0.03% 558
2019
Q3 		$13K Buy
+2,500
New +$13.3K ﹤0.01% 919

Other funds holding CPRX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

NumerixS Investment Technologies's CPRX Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Catalyst Pharmaceutical (CPRX) in Q3 2020, closing a stake of 12,200 shares — an estimated $56K sold.

NumerixS Investment Technologies first reported a position in CPRX in Q3 2019 and held it in 4 quarters. The position peaked at $158K in Q4 2019. 142 funds tracked by Wall St. Rank hold CPRX as of Q3 2020.

  • NumerixS Investment Technologies reported no remaining Catalyst Pharmaceutical position as of Q3 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 12,200 Catalyst Pharmaceutical shares in Q3 2020, an estimated $56K.
  • NumerixS Investment Technologies first reported a position in Catalyst Pharmaceutical in Q3 2019 and held it in 4 quarters.
  • NumerixS Investment Technologies's Catalyst Pharmaceutical position peaked at $158K in Q4 2019.
  • 142 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.